
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has shown a solid performance in recent quarters, buoyed by its strong presence in Asia and effective wealth management strategies. However, there are concerns regarding its valuation, as it is perceived to be somewhat overbought, trading over 2x book value with limited earnings growth expected in the near future. Despite these concerns, many experts highlight its decent dividend yield and ongoing growth potential, particularly in its Asian markets. The recent implementation of a tax on MFC products for mainland Chinese residents adds a layer of uncertainty. Overall, the sentiment among analysts is cautiously optimistic, with a call for careful monitoring of market conditions and potential entry points for investment.
Favourite Canadian lifeco and your 12 month outlook? The one that really stands out is Manulife (MFC-T). He likes that life insurance can re-price their products in the given market here. We are seeing premiums increasing. If this continues going the way it is, he could see $20 on this stock. 3% dividend yield.
A couple of years away from a dividend raise. Have really good insurance growth in Asia and good success in wealth management. A spectre of higher rates means of the higher valuation. His one-year target would be $21. Buy territory would be at around $18. 2.6% dividend.